Rx (Prescription Medicine)
USD $ 85.00
Pazeqol 400mg Tablet 是一种含有活性成分 Pazopanib 的药物。Pazopanib 是一种酪氨酸激酶抑制剂，通过阻断某些参与癌细胞生长与转移的酪氨酸激酶的活性来发挥作用。通过抑制这些蛋白质，Pazeqol 有助于减缓或停止肿瘤的生长，并可防止其扩散至身体其他部位。
Pazeqol 400mg Tablet 主要用于治疗晚期肾细胞癌（肾癌）和晚期软组织肉瘤（软组织肉瘤）的成人患者。常规剂量为 800mg，每日两次，服用时需在两剂之间间隔 1 小时并随食物服用。务必遵循医生的处方剂量和疗程。常见不良反应可能包括腹泻、高血压、头发颜色改变、恶心、疲劳和腹痛。少见但严重的不良反应也可能发生，因此如出现任何异常症状，请立即向您的医疗提供者报告。请将 Pazeqol 400mg Tablets 存放于室温，远离潮湿和热源，并置于儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Pazopanib 400 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
